Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Al-Sarraf

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Cancer Treatment Reports|July 1, 1987
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University StudyM Al-Sarraf, B Metch, J Kish, et al.
Cancer Treatment Reports|January 1, 1982
Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group studyM Al-Sarraf, W Fletcher, N Oishi, et al.
The Laryngoscope|January 1, 1993
Implications of positive surgical marginsJ R Jacobs, K Ahmad, R Casiano, et al.
American Journal of Surgery|October 1, 1984
Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancerA Weaver, S Fleming, J Ensley, et al.
The American Surgeon|July 1, 1990
The effects of chemotherapy on murine wound healing and orocutaneous fistula closureT Whittle, C E Lucas, A M Ledgerwood, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1997
Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24M Al-Sarraf, T F Pajak, R W Byhardt, et al.
Cancer|April 15, 1983
Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neckD A Decker, A Drelichman, J Jacobs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancerJ Ensley, J Kish, E Tapazoglou, et al.
Cancer|February 1, 1991
The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapyM Hussain, J A Kish, L Crane, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 1, 1991
5-year results of cisplatin and fluorouracil infusion in head and neck cancerJ R Jacobs, K K Fu, L D Lowry, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Cancer Treatment Reports|July 1, 1987
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University StudyM Al-Sarraf, B Metch, J Kish, et al.
Cancer Treatment Reports|January 1, 1982
Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group studyM Al-Sarraf, W Fletcher, N Oishi, et al.
The Laryngoscope|January 1, 1993
Implications of positive surgical marginsJ R Jacobs, K Ahmad, R Casiano, et al.
American Journal of Surgery|October 1, 1984
Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancerA Weaver, S Fleming, J Ensley, et al.
The American Surgeon|July 1, 1990
The effects of chemotherapy on murine wound healing and orocutaneous fistula closureT Whittle, C E Lucas, A M Ledgerwood, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1997
Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24M Al-Sarraf, T F Pajak, R W Byhardt, et al.
Cancer|April 15, 1983
Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neckD A Decker, A Drelichman, J Jacobs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancerJ Ensley, J Kish, E Tapazoglou, et al.
Cancer|February 1, 1991
The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapyM Hussain, J A Kish, L Crane, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 1, 1991
5-year results of cisplatin and fluorouracil infusion in head and neck cancerJ R Jacobs, K K Fu, L D Lowry, et al.
Pageof 15